223 related articles for article (PubMed ID: 27043336)
1. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
Merritt BG; Snow SN; Longley BJ
Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Cribier B
Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS3-VS11. PubMed ID: 30477681
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins.
Anderson-Dockter H; Clark T; Iwamoto S; Lu M; Fiore D; Falanga JK; Falanga V
Dermatol Surg; 2012 Aug; 38(8):1357-66. PubMed ID: 22691048
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
Abbas O; Richards JE; Mahalingam M
Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
8. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
Bartoš V
Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
[TBL] [Abstract][Full Text] [Related]
9. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
10. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
11. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors.
Vidal CI; Goldberg M; Burstein DE; Emanuel HJ; Emanuel PO
Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297
[TBL] [Abstract][Full Text] [Related]
12. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma.
Battistella M; Peltre B; Cribier B
Am J Dermatopathol; 2014 Aug; 36(8):643-50. PubMed ID: 23719479
[TBL] [Abstract][Full Text] [Related]
13. Can smoking and/or occupational UV exposure have any role in the development of the morpheaform basal cell carcinoma? A critical role for peritumoral mast cells.
Erbagci Z; Erkiliç S
Int J Dermatol; 2002 May; 41(5):275-8. PubMed ID: 12100702
[TBL] [Abstract][Full Text] [Related]
14. Pan-cytokeratin markers for rapid frozen section immunocytochemistry from head and facial Mohs cases of basal cell carcinoma: a comparison and evaluation to determine the marker of choice.
Orchard GE; Wojcik K; Shams F; Georgaki E; Quaye CJ; Fernando P; Torres J; Ismail F; Shams M
Br J Biomed Sci; 2015; 72(2):61-6. PubMed ID: 26126321
[TBL] [Abstract][Full Text] [Related]
15. A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.
Christian MM; Moy RL; Wagner RF; Yen-Moore A
Dermatol Surg; 2001 May; 27(5):441-5. PubMed ID: 11359490
[TBL] [Abstract][Full Text] [Related]
16. Expression of rasGTPase activating protein in basal cell carcinoma of the skin.
Barshack I; Goldberg I; Davidson B; Ravid A; Schiby G; Kopolovic J; Leviav A; Friedman E
Mod Pathol; 1998 Mar; 11(3):271-5. PubMed ID: 9521474
[TBL] [Abstract][Full Text] [Related]
17. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
18. Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma.
Chaudet KM; Stagner AM; Nazarian RM
Am J Dermatopathol; 2022 Dec; 44(12):886-890. PubMed ID: 36197047
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma.
Kurzen H; Esposito L; Langbein L; Hartschuh W
Am J Dermatopathol; 2001 Dec; 23(6):501-9. PubMed ID: 11801790
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
Kazantseva IA; Khlebnikova AN; Babaev VR
Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]